Pattern of adverse drug reactions reported at the adverse drug reaction monitoring centre at tertiary care teaching hospital in North India
Keywords:Adverse events, ADRs causality, Preventability, Severity, Adverse drug monitoring centre, Pharmacovigilance, WHO causality scale
Background: The aim of the present study was to determine the pattern of adverse drug reactions (ADRs) reported at ADR monitoring centre (AMC) in Punjab.
Methods: This observational retrospective study was done in department of Pharmacology, GGS Medical College and Hospital, Faridkot from September 2020 to August 2021. A total of 148 ADRs were reported during the study period. Each ADR was analyzed for demographic data and characteristics of ADR. Assessment of causality, severity and preventability was done according to WHO UMC scale, modified Hartwig and Siegel scale and Modified Schumock and Thornton Preventability Scale respectively.
Results: A total of 148 ADRs were reported from both outpatients and in patients of various departments. Most of the ADRs were found in males (55%) and patients of age group 31-45 years (33%). Majority of ADRs were reported from dermatology department (40%). Overall, 38% of ADRs were due to antimicrobial drugs. Most of the ADRs were reported as possible (57%), followed by probable (41%) as per WHO causality assessment. Most of the ADRs were moderate severity (83%). 97% of the ADRs were found to be definitely preventable type.
Conclusions: We concluded that most of the ADRs were reported from antimicrobial drugs, so it is advisable to have close monitoring of the antimicrobial drug therapy to prevent ADRs in the patients. Although the majority of ADRs were moderate in nature but mostly were recovered. The study of ADRs in a particular institute using demographic patterns will contribute to patient safety by sensitizing the clinicians in that particular institute.
Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study. Persp Clin Res. 2013;4(4):204.
Kumar A, Kansal D, Sharma PK, Bhardwaz A, Sawaraj S. To study the pattern of adverse drug reactions among patients hospitalized in the medical wards pf a tertiary care hospital. Int J Basic Clin Pharmacol. 2016;5:1972-7.
The use of WHO-UMC system for standardized case causality assessment. Available at: https:/www. who.int/medicines/areas/quality_safety/safety _efficacy/WHO casuality_ assessment.pdf. Accessed on 28 October 2019.
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.
Schumock GT, Thornton JW. Focussing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.
Badar VA, Parulekar V, Garate P. A surveillance study of adverse drug reactions in a tertiary care teaching hospital in India. Int J of Res in Pharmacol Pharmacother. 2018;7(2):120-9.
Lihite RJ, Lakhar M, Das S, Hazarika D, Kotni M, Maqbool M et al. A study on adverse drug reactions in a tertiary care hospital of northeast India. Alex J Med. 2017;53(2):151-6.
Venkatasubbaiah M, Reddy PD, Satyanarayana SV. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital. Alex J Med. 2018; 54(4):597-603.
Zaman SU, Ramesh L, Priya BV, Beedimani RS, Manikanta M. Adverse drug reactions: An analysis of spontaneous reports. Natl J Physiol Pharm Pharmacol. 2021;11(2):141-6.